T Cell Engineering
Personalized cell therapy has become a growing option for treatment of cancer and many other ailments. See MoreUsing engineered T cells that express chimeric antigen receptors or modified T cell receptors are becoming pivotal new approaches for targeting cancer cells.
The process of manufacturing genetically-modified T cells for cancer therapies or other applications may initially require the isolation of T cells or T cell subsets from Leukopaks or whole blood samples . STEMCELL Technologies provides fast, easy and column-free or cell separation platforms for the isolation of highly purified T cells in as little as 8 minutes. The purified cells are immediately ready for T cell activation and expansion, the next steps in the T cell engineering workflow.
- Video (1:57) Fast and Easy Cell Isolation with EasySep™
- Video (1:44) Cell Isolation Directly from Whole Blood without Density Gradient Centrifugation or RBC Lysis: EasySep™ Direct
- Video (2:19) RosetteSep™: Cell Isolation Directly From Whole Blood Without Columns or Magnets
- Brochure Tools to Streamline your T Cell Research